litlas
Log inCreate account

Charles L. Raison

Active 1999–2024

78
Papers
27,741
Citations
60
h-index
73
i10-index

Citations

Citations per year for Charles L. Raison1983: 2 citations1991: 1 citations1997: 2 citations2002: 2 citations2003: 6 citations2004: 20 citations2005: 55 citations2006: 58 citations2007: 99 citations2008: 123 citations2009: 160 citations2010: 191 citations2011: 212 citations2012: 302 citations2013: 323 citations2014: 378 citations2015: 412 citations2016: 425 citations2017: 412 citations2018: 450 citations2019: 1,204 citations2020: 1,230 citations2021: 1,240 citations2022: 953 citations2023: 691 citations2024: 1,053 citations2025: 636 citations2026: 23 citations1984–1990: no citations, so these years are not shown1992–1996: no citations, so these years are not shown1998–2001: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,061 citing papers, 25.6% of this breakdownChina: 1,189 citing papers, 9.9% of this breakdownUnited Kingdom: 857 citing papers, 7.2% of this breakdownCanada: 605 citing papers, 5.1% of this breakdownGermany: 594 citing papers, 5% of this breakdownAustralia: 502 citing papers, 4.2% of this breakdownItaly: 482 citing papers, 4% of this breakdownNetherlands: 349 citing papers, 2.9% of this breakdownBrazil: 305 citing papers, 2.5% of this breakdownFrance: 288 citing papers, 2.4% of this breakdownSpain: 261 citing papers, 2.2% of this breakdownSweden: 205 citing papers, 1.7% of this breakdown
0%25.6%Other 27.3%

Institutions

Fields

  • Neuroscience43.5%
  • Medicine24.6%
  • Biochemistry, Genetics and Molecular Biology13.3%
  • Psychology11.2%
  • Immunology and Microbiology1.7%
  • Environmental Science1.3%
  • Other4.4%

Topics

  • Tryptophan and brain disorders16.7%
  • Stress Responses and Cortisol11.1%
  • Gut microbiota and health4.1%
  • Neuroinflammation and Neurodegeneration Mechanisms3.9%
  • Treatment of Major Depression2.4%
  • Bipolar Disorder and Treatment1.7%
  • Other60.1%

Coauthors

All papers

Open in search
  1. The role of inflammation in depression: from evolutionary imperative to modern treatment target

    Authors: Andrew H. Miller, Charles L. Raison - Nature reviews. Immunology 2015 cited by 3,752

  2. Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression

    Authors: Andrew H. Miller, Vladimir Maletic, Charles L. Raison - Biological Psychiatry 2009 cited by 3,824

  3. Single-Dose Psilocybin Treatment for Major Depressive Disorder

    Authors: Charles L. Raison, Gerard Sanacora, Joshua Woolley, Keith G. Heinzerling, Boadie W. Dunlop, Randall Brown, Rishi Kakar, Michael Hassman, Rupal Trivedi, Reid Robison, Natalie Gukasyan, Sandeep M. Nayak, Xiaojue Hu, Kelley C. O’Donnell, Benjamin Kelmendi, Jordan Sloshower, Andrew Penn, Ellen Bradley, Daniel F. Kelly, Tanja Mletzko, Christopher R. Nicholas, Paul R. Hutson, Gary Tarpley, Malynn Utzinger, Kelsey Lenoch, Kasia Warchol, Theraysa Gapasin, Mike C. Davis, Courtney Nelson-Douthit, Steffanie H Wilson, Carrie Brown, William Linton, Matthew W. Johnson, Stephen Ross, Roland R. Griffiths - JAMA 2023 cited by 484

  4. Peripheral cytokine and chemokine alterations in depression: a meta‐analysis of 82 studies

    Authors: Cristiano A. Köhler, Thiago Holanda Freitas, Michaël Maes, Nayanna Quezado de Andrade, C. S. Liu, Brisa S. Fernandes, Brendon Stubbs, Marco Solmi, Nicola Veronese, Nathan Herrmann, Charles L. Raison, Brian J. Miller, Krista L. Lanctôt, André F. Carvalho - Acta Psychiatrica Scandinavica 2017 cited by 1,426

  5. American Gut: an Open Platform for Citizen Science Microbiome Research

    Authors: Daniel McDonald, Embriette R. Hyde, Justine W. Debelius, James T. Morton, Antonio González-Torres, Gail Ackermann, Alexander A. Aksenov, Bahar Behsaz, Caitriona Brennan, Yingfeng Chen, Lindsay DeRight Goldasich, Pieter C. Dorrestein, Robert R. Dunn, Ashkaan K. Fahimipour, James Gaffney, Jack A. Gilbert, Grant Gogul, Jessica L. Green, Philip Hugenholtz, Greg Humphrey, Curtis Huttenhower, Matthew Jackson, Stefan Janssen, Dilip V. Jeste, Lingjing Jiang, Scott T. Kelley, Dan Knights, Tomasz Kościółek, Joshua Ladau, Jeff Leach, Clarisse Marotz, Dmitry Meleshko, Alexey V. Melnik, Jessica L. Metcalf, Hosein Mohimani, Emmanuel Montassier, José A. Navas-Molina, Tanya T. Nguyen, Shyamal D. Peddada, Pavel A. Pevzner, Katherine S. Pollard, Ali Rahnavard, Adam Robbins‐Pianka, Naseer Sangwan, Joshua Shorenstein, Larry Smarr, Se Jin Song, Timothy Spector, Austin D. Swafford, Varykina G. Thackray, Luke Thompson, Anupriya Tripathi, Yoshiki Vázquez‐Baeza, Alison Vrbanac, Paul E. Wischmeyer, Elaine Wolfe, Qiyun Zhu, Rob Knight, Allison E. Mann, Amnon Amir, Angel Frazier, Cameron Martino, Carlito B. Lebrilla, Catherine Lozupone, Cecil M. Lewis, Charles L. Raison, Chi Zhang, Christian L. Lauber, Christina Warinner, Christopher A. Lowry, Chris Callewaert, Cinnamon S. Bloss, Dana Willner, Daniela Domingos Galzerani, David J. Gonzalez, David A. Mills, Deepak Chopra, Dirk Gevers, Donna Berg-Lyons, Dorothy D. Sears, Doug Wendel, Elijah Lovelace, Emily C. Pierce, Emily TerAvest, Evan Bolyen, Frederic D. Bushman, Gary D. Wu, George M. Church, Gordon Saxe, Hanna D. Holscher, Ivo Ugrina, J German, J. Gregory Caporaso, Jacob M. Wozniak, Jacqueline Kerr, Jacques Ravel, James D. Lewis, Jan S. Suchodolski, Janet Jansson, Jarrad Hampton‐Marcell and 68 more - mSystems 2018 cited by 906

  6. A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression

    Authors: Charles L. Raison, Robin E. Rutherford, Bobbi J. Woolwine, Shuo Chen, Pamela J. Schettler, Daniel Drake, Ebrahim Haroon, Andrew H. Miller - JAMA Psychiatry 2012 cited by 1,579

  7. Cytokines sing the blues: inflammation and the pathogenesis of depression

    Authors: Charles L. Raison, Lucile Capuron, Andrew H. Miller - Trends in Immunology 2005 cited by 2,988

  8. CYTOKINE TARGETS IN THE BRAIN: IMPACT ON NEUROTRANSMITTERS AND NEUROCIRCUITS

    Authors: Andrew H. Miller, Ebrahim Haroon, Charles L. Raison, Jennifer C. Felger - Depression and Anxiety 2013 cited by 882

  9. Psychoneuroimmunology Meets Neuropsychopharmacology: Translational Implications of the Impact of Inflammation on Behavior

    Authors: Ebrahim Haroon, Charles L. Raison, Andrew H. Miller - Neuropsychopharmacology 2011 cited by 984

  10. Psilocybin desynchronizes the human brain

    Authors: Joshua S. Siegel, Subha Subramanian, Demetrius Perry, Benjamin P. Kay, Evan M. Gordon, Timothy O. Laumann, Travis R. Reneau, Nicholas V. Metcalf, Ravi V. Chacko, Caterina Gratton, Christine Horan, Samuel R. Krimmel, Joshua S. Shimony, Julia Schweiger, Dean F. Wong, David A. Bender, Kristen M. Scheidter, Forrest I. Whiting, Jonah A. Padawer-Curry, Russell T. Shinohara, Yong Chen, Julia Moser, Essa Yacoub, Steven M. Nelson, Luca Vizioli, Damien A. Fair, Eric J. Lenze, Robin Carhart‐Harris, Charles L. Raison, Marcus E. Raichle, Abraham Z. Snyder, Ginger E. Nicol, Nico U.F. Dosenbach - Nature 2024 cited by 237

  11. Peripheral Alterations in Cytokine and Chemokine Levels After Antidepressant Drug Treatment for Major Depressive Disorder: Systematic Review and Meta-Analysis

    Authors: Cristiano A. Köhler, Thiago Holanda Freitas, Brendon Stubbs, Michaël Maes, Marco Solmi, Nicola Veronese, Nayanna Quezado de Andrade, Gerwyn Morris, Brisa S. Fernandes, André R. Brunoni, Nathan Herrmann, Charles L. Raison, Brian J. Miller, Krista L. Lanctôt, André F. Carvalho - Molecular Neurobiology 2017 cited by 454

  12. The experimental effects of psilocybin on symptoms of anxiety and depression: A meta-analysis

    Authors: Simon B. Goldberg, Brian T. Pace, Christopher R. Nicholas, Charles L. Raison, Paul R. Hutson - Psychiatry Research 2020 cited by 232

  13. Burning down the house: reinventing drug discovery in psychiatry for the development of targeted therapies

    Authors: Andrew H. Miller, Charles L. Raison - Molecular Psychiatry 2022 cited by 69

  14. Importance of Integrating Spiritual, Existential, Religious, and Theological Components in Psychedelic-Assisted Therapies

    Authors: Roman Palitsky, Deanna M. Kaplan, Caroline Peacock, Ali John Zarrabi, Jessica L. Maples‐Keller, George H. Grant, Boadie W. Dunlop, Charles L. Raison - JAMA Psychiatry 2023 cited by 86

  15. Is Depression an Inflammatory Disorder?

    Authors: Charles L. Raison, Andrew H. Miller - Current Psychiatry Reports 2011 cited by 522

  16. Effects of Naturalistic Psychedelic Use on Depression, Anxiety, and Well-Being: Associations With Patterns of Use, Reported Harms, and Transformative Mental States

    Authors: Charles L. Raison, Rakesh Jain, Andrew Penn, Steven P. Cole, Saundra Jain - Frontiers in Psychiatry 2022 cited by 75

  17. Activation of Central Nervous System Inflammatory Pathways by Interferon-Alpha: Relationship to Monoamines and Depression

    Authors: Charles L. Raison, Andrey Borisov, Matthias Majer, Daniel Drake, Giuseppe Pagnoni, Bobbi J. Woolwine, Gerald Vogt, Breanne Massung, Andrew H. Miller - Biological Psychiatry 2008 cited by 370

  18. The IL-6 antagonist tocilizumab is associated with worse depression and related symptoms in the medically ill

    Authors: Jennifer M. Knight, Erin S. Costanzo, Suraj Singh, Ziyan Yin, Anikó Szabó, Deepa S. Pawar, Cecilia J. Hillard, J. Douglas Rizzo, Anita D’Souza, Marcelo C. Pasquini, Christopher L. Coe, Michael R. Irwin, Charles L. Raison, William R. Drobyski - Translational Psychiatry 2021 cited by 75

  19. When Not Enough Is Too Much: The Role of Insufficient Glucocorticoid Signaling in the Pathophysiology of Stress-Related Disorders

    Authors: Charles L. Raison, Andrew H. Miller - American Journal of Psychiatry 2003 cited by 1,194

  20. Immunization with a heat-killed preparation of the environmental bacterium Mycobacterium vaccae promotes stress resilience in mice

    Authors: Stefan O. Reber, Philip H. Siebler, Nina C. Donner, James T. Morton, David Glenn Smith, Jared M. Kopelman, Kenneth R. Lowe, Kristen J. Wheeler, James H. Fox, James E. Hassell, Benjamin N. Greenwood, Charline Jansch, Anja Lechner, Dominic Schmidt, Nicole Uschold‐Schmidt, Andrea M. Füchsl, Dominik Langgartner, Frederick R. Walker, Matthew W. Hale, Gerardo López Pérez, Will Van Treuren, Antonio González, Andrea L. Halweg‐Edwards, Monika Fleshner, Charles L. Raison, G.A.W. Rook, Shyamal D. Peddada, Rob Knight, Christopher A. Lowry - National Academy of Sciences, Proceedings of the National Academy of Sciences 2016 cited by 236

  21. The evolutionary significance of depression in Pathogen Host Defense (PATHOS-D)

    Authors: Charles L. Raison, Andrew H. Miller - Molecular Psychiatry 2012 cited by 253

  22. Whole-Body Hyperthermia for the Treatment of Major Depressive Disorder

    Authors: Clemens Janssen, Christopher A. Lowry, Matthias R. Mehl, John J. B. Allen, Kimberly Kelly, Danielle E. Gartner, Angelica Medrano, Tommy Begay, Kelly E. Rentscher, Joshua J. White, Andrew Fridman, Levi J. Roberts, Megan L. Robbins, Kay-Uwe Hanusch, Steven P. Cole, Charles L. Raison - JAMA Psychiatry 2016 cited by 151

  23. Extracellular Vesicle Biomarkers Reveal Inhibition of Neuroinflammation by Infliximab in Association with Antidepressant Response in Adults with Bipolar Depression

    Authors: Rodrigo B. Mansur, Francheska Delgado‐Peraza, Mehala Subramaniapillai, Yena Lee, Michelle Iacobucci, Nelson B. Rodrigues, Joshua D. Rosenblat, Elisa Brietzke, Victoria E. Cosgrove, Nicole E. Kramer, Trisha Suppes, Charles L. Raison, Sahil Chawla, Carlos Nogueras‐Ortiz, Roger S. McIntyre, Dimitrios Kapogiannis - Cells 2020 cited by 67

  24. Microbial ‘Old Friends’, immunoregulation and stress resilience

    Authors: G.A.W. Rook, Christopher A. Lowry, Charles L. Raison - Evolution Medicine and Public Health 2013 cited by 242